Participants
B liver disease, thrombotic or hemorrhagic diseases
MALIGNANT TUMOR, THROMBOCYTOPENIA, METASTASIS, LIVER DISEASE
The eligibility criteria were: patients who were 18 years or more when signing the informed consent with Child–Pugh class A or B liver disease, or with Child–Pugh class C liver disease but can be hospitalized at least between days 5 and 10 and were undergoing for elective invasive treatment probably needing platelet transfusion, and the PLT was < 50 × 10Patients who had any other causes of thrombocytopenia, any solid malignant tumor required systemic chemotherapy or with metastasis, past or present thrombotic or hemorrhagic diseases, or with a history of liver transplantation were excluded (Supplementary material 2).